Abstract
Milbemycin antibiotics are produced by Streptomyces hygroscopicus subsp. aureolacrimosus and a newly isolated Streptomyces bingchenggensis, respectively. According to the biosynthetic pathway of milbemycins generated by S. hygroscopicus subsp. aureolacrimosus, a rational screening procedure with UV irradiation and N-methyl-N′-nitroso-N-nitrosoguanidine (NTG) mutation was performed to obtain high milbemycin-producing S. bingchenggensis. Aminoacetic acid (Glycine)-resistant mutants (AAr), propionate-resistant mutants (PRPr), streptomycin-resistant mutants (STRr) and 2-deoxy-d-glucose-resistant mutants (DOGr) were selected successively. A strain S. bingchenggensis BC-109-6 with AAr, PRPr, STRr and DOGr was obtained and its production of milbemycin A3 and A4 reached 1,450 μg/ml, which was 80% higher than that of the ancestral strain S. bingchenggensis BC-101-4. The subculture experiments indicated that the hereditary characteristic of high productivity of S. bingchenggensis BC-109-6 was stable. The production of milbemycin A3 and A4 by S. bingchenggensis BC-109-6 in a 50-l fermentor could reach 1,380 μg/ml after 360 h batch fermentation.
Similar content being viewed by others
References
Beltrametti F, Jovetic S, Feroggio M, Gastaldo L, Selva E, Marinelli F (2004) Valine influences production and complex composition of glycopeptide antibiotic A40926 in fermentations of Nonomuraea sp. ATCC 39727. J Antibiot 57:37–44
Beltrametti F, Rossi R, Selva E, Marinelli F (2006) Antibiotic production improvement in the rare actinomycete Planobispora rosea by selection of mutants resistant to the aminoglycosides streptomycin and gentamycin and rifamycin. J Ind Microbiol Biotechnol 33:283–288. doi:10.1007/s10295-005-0061-4
Chen JM, Xu LT (1991) Analysis of antibiotic industry, 2nd edn. Chinese Press of Pharmaceutical Science, Beijing, pp 109–139. ISBN 7-5067-0353-X
Davies GH, Green RH (1991) Avermectins and milbemycins. Chem Soc Rev 20:211–269. doi:10.1039/cs9912000211
Hosoya Y, Okamoto S, Muramatsu H, Ochi K (1998) Acquisition of certain streptomycin-resistant (str) mutations enhances antibiotic production in bacteria. Antimicrob Agents Chemother 42:2041–2047
Hu H, Ochi K (2001) Novel approach for improvement the productivity of antibiotic-producing strains by inducing combined resistant mutations. Appl Environ Microbiol 67:1885–1892. doi:10.1128/AEM.67.4.1885-1892.2001
Hu H, Zhang Q, Ochi K (2002) Activation of antibiotic biosynthesis by specified mutations in the rpoB gene (encoding the RNApolymerase beta subunit) of Streptomyces lividans. J Bacteriol 184:3984–3991. doi:10.1128/JB.184.14.3984-3991.2002
Ide J, Okazaki T, Ono M, Saito A, Nakagawa K, Naito S, Sato K, Tanaka K, Yoshikawa H, Ando M, Katsumi S, Matsumoto K, Toyama T, Shibano M, Abe M (1993) Milbemycin: discovery and development. Annu Rep Snakyo Res Lab 45:1–98
Ikeda H, Omura S (1995) Control of avermectin biosynthesis in Streptomyces avermitilis for the selective production of a useful component. J Antibiot 48:549–561
Ikeda H, Omura S (1997) Avermectin biosynthesis. Chem Rev 97:2591–2609. doi:10.1021/cr960023p
Jin ZH, Wang MR, Cen PL (2002a) Improvement of industry-applied rifamycin B-producing strain, Amycolatopsis mediterranei, by rational screening. J Gen Appl Microbiol 48:329–334. doi:10.2323/jgam.48.329
Jin ZH, Wang MR, Cen PL (2002b) Production of teicoplanin by valine analogue-resistant mutant strains of Actinoplanes teichomyceticus. Appl Microbiol Biotechnol 58:63–66. doi:10.1007/s00253-001-0872-9
Jin ZH, Lei YL, Lin JP, Cen PL (2006) Improvement of pristinamycin-producing Streptomyces pristinaespialis by rational screening. World J Microbiol Biotechnol 22:129–134. doi:10.1007/s11274-005-9008-1
Nonaka K, Kumasaka C, Okamoto Y, Maruyama F, Yoshikawa H (1999) Bioconversion of milbemycin-related compounds: biosynthetic pathway of milbemycins. J Antibiot 52:109–116
Ochi K (1987) Metabolic initiation of differentiation and secondary metabolism by Streptomyces griseus: significance of the stringent response (ppGpp) and GTP content in relation to a factor. J Bacteriol 169:3608–3616
Olano C, Lombo F, Mendez C, Salas JA (2008) Improving production of bioactive secondary metabolites in actinomycetes by metabolic engineering. Metab Eng 10:281–292. doi:10.1016/j.ymben.2008.07.001
Ono M, Mishima H, Takiguchi Y, Terao M (1983) Milbemycins, a new family of macrolide antibiotics studies on the biosynthesis of milbemycins α2, α4 and D using 13C labeled precursors. J Antibiot 36:991–999
Parekh S, Vinci VA, Strobel RJ (2000) Improvement of microbial strains and fermentation processes. Appl Microbiol Biotechnol 54:287–301. doi:10.1007/s002530000403
Rowlands RT (1984) Industrial strain improvement: mutagenesis and random screening procedures. Enzyme Microb Technol 6:3–10. doi:10.1016/0141-0229(84)90070-X
Shima J, Hesketh A, Okamoto S, Kawamoto S, Ochi K (1996) Induction of actinorhodin production by rpsL (encoding ribosomal protein S12) mutations that confer streptomycin resistance in Streptomyces lividans and Streptomyces coelicolor A3(2). J Bacteriol 178:7276–7284
Shoop WL, Mrozik H, Fisher MH (1995) Structure and activity of avermectins and milbemycins in animal health. Vet Parasitol 59:139–156. doi:10.1016/0304-4017(94)00743-V
Tamehiro N, Hosaka T, Xu J, Hu H, Otake N, Ochi K (2003) Innovative approach for improvement of an antibiotic-overproducing industrial strain of Streptomyces albus. Appl Environ Microbiol 69:6412–6417. doi:10.1128/AEM.69.11.6412-6417.2003
Tsou HR, Ahmed ZH, Fiale RR, Bullock MW (1989) Biosynthetic origin of the carbon skeleton and oxygen atoms of the LL-F28249α: a potent antibiotic macrolide. J Antibiot 41:398–406
Vinci VA, Byng G (1999) Manual of industrial microbiology and biotechnology. ASM, Washington
Xiang WS, Wang JD, Wang XJ (2007a) Further new milbemycin antibiotics from Streptomyces bingchenggensis. J Antibiot 60:608–613. doi:10.1038/ja.2007.78
Xiang WS, Wang JD, Wang XJ (2007b) Two new milbemycins from Streptomyces bingchenggensis fermentation, isolation, structure elucidation and biological properties. J Antibiot 60:351–356. doi:10.1038/ja.2007.47
Xiang WS, Wang JD, Fan HM, Wang XJ (2008) New seco-milbemycins from Streptomyces bingchenggensis: fermentation, isolation and structure elucidation. J Antibiot 61:26–32. doi:10.1038/ja.2008.105
Acknowledgment
This study was financially supported by the National Key Technology R&D Program (No. 2006BAD31B02), the National Natural Science Foundation of China (30571234 and 30771427), and the Outstanding Youth Foundation of Heilongjiang Province (No. JC200706).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, XJ., Wang, XC. & Xiang, WS. Improvement of milbemycin-producing Streptomyces bingchenggensis by rational screening of ultraviolet- and chemically induced mutants. World J Microbiol Biotechnol 25, 1051–1056 (2009). https://doi.org/10.1007/s11274-009-9986-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11274-009-9986-5